Viewing Study NCT01802333


Ignite Creation Date: 2025-12-25 @ 2:42 AM
Ignite Modification Date: 2026-02-26 @ 5:10 PM
Study NCT ID: NCT01802333
Status: COMPLETED
Last Update Posted: 2018-12-19
First Post: 2013-02-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
None Untreated Adult Acute Myeloid Leukemia View
Keywords: